As shown in Fig. 5, mesenchymal marker β-catenin decreased, while epithelial marker E-cadherin increased in BI853520 treated ovarian cancer cells, which showed that BI853520 inhibits EMT process in ovarian cancer cells (Fig. 5C, D). This evidence concerns the gene CDH1 and ovarian cancer.